Sign In
Buy ALXN
$182.50
+0 (+0%)
At Close: May 27, 2022
Alexion Pharmaceuticals, Inc.'s (NASDAQ:ALXN) Stock Been Rising: Are Strong Financials Guiding The Market?
03:25pm, Monday, 13'th Jul 2020
Alexion Pharmaceuticals' (NASDAQ:ALXN) stock is up by 9.5% over the past three months. Since the market usually pay...
Top Stocks To Buy On A Sell-Off
11:29am, Monday, 13'th Jul 2020
Let your winners continue winning, but begin compiling a watch list to buy on a pullback. These top-ranked industries are the best hunting ground for ideas.
Envestnet Asset Management Inc. Boosts Stock Position in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
06:26am, Monday, 13'th Jul 2020
Envestnet Asset Management Inc. grew its stake in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 11.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange C
FY2020 EPS Estimates for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Raised by Analyst
02:32am, Monday, 13'th Jul 2020
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) – Stock analysts at Cantor Fitzgerald boosted their FY2020 earnings per share (EPS) estimates for Alexion Pharmaceuticals in a research note issued to inv
3 Moneymaker Stocks to Buy If the Market Crashes | The Motley Fool
10:36am, Sunday, 12'th Jul 2020
Focusing on companies that generate a boatload of cash can be a smart way to navigate a stock market crash.
Exane Derivatives Sells 4,928 Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
07:26am, Sunday, 12'th Jul 2020
Exane Derivatives trimmed its position in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 80.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange
3 Moneymaker Stocks to Buy If the Market Crashes
06:36am, Sunday, 12'th Jul 2020
Focusing on companies that generate a boatload of cash can be a smart way to navigate a stock market crash.
Annexon Initiates $100 Million IPO Effort
11:00am, Saturday, 11'th Jul 2020
Annexon aims to raise $100 million in an IPO, although the final figure may differ. The firm is advancing treatments for various autoimmune and neurodegenerative disorders.
Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)
07:00am, Saturday, 11'th Jul 2020
Alexion Pharmaceuticals represents a quintessential example of a true growth stock. There is always risk associated with investing in growth stocks.
Alexion Pharmaceuticals: Growth At A Reasonable Price - ValueWalk
07:26pm, Friday, 10'th Jul 2020
I find it very interesting that Alexion Pharmaceuticals, Inc. (ALXN) after going public in 2001, did not generate their first profit until
Apellis Trial Progress And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:APLS)
06:44am, Thursday, 09'th Jul 2020
Apellis completes enrolment in two phase 3 studies. Novocure's hepanova trial advances in liver cancer.
British judge orders Christopher Steele to pay damages to Russian bankers named in dossier
06:16pm, Wednesday, 08'th Jul 2020
A court in the United Kingdom ordered British ex-spy Christopher Steele to pay thousands in damages to two Russian bankers named in the former MI6 agent’s dossier as having “illicit” financial t
Were Hedge Funds Right About Piling Into Alexion Pharmaceuticals, Inc. (ALXN)?
05:21pm, Wednesday, 08'th Jul 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
5 Greenblatt Magic Formula Biotech Stocks to Weather the Summer Coronavirus Storm
10:48pm, Tuesday, 07'th Jul 2020
Stocks to consider as biotech company Novavax gets $1.6 billion in federal aid for Covie-19 vaccine Continue reading...
5 Greenblatt Magic Formula Biotech Stocks to Weather the Summer Coronavirus Storm
05:48pm, Tuesday, 07'th Jul 2020
In light of Novavax Inc. (NASDAQ:NVAX) getting $1.6 billion in federal aid for its coronavirus vaccine candidate, investors might find opportunities in biotechnology stocks that have high financial st
